P007 Clinching the Diagnosis: Dermpath, CPC, Testing and Beyond
DESCRIPTION
The majority of dermatological conditions can be diagnosed through an office visit, often with the support of a biopsy interpreted by a dermatopathologist. Sometimes, correlating clinical findings with pathological results (CPC) is crucial for a definitive diagnosis. In certain cases, further tests may be necessary, such as immunofluorescence or molecular studies like PCR, next-generation sequencing, or FISH. This session will concentrate on the diagnostic aspects of dermatological conditions that extend beyond the clinical examination of the patient, including case examples.
LEARNING OBJECTIVES
List examples of molecular studies that can be helpful in diagnosing dermatologic conditions.
Discuss the impact of molecular studies in the diagnosis and classification of melanoma and atypical melanocytic/spitzoid neoplasms.
Identify situations in which PCR testing can assist in the diagnosis of dermatologic conditions.
SCHEDULE
8:00 PM
Introduction
Jacqueline M. Junkins-Hopkins, MD, FAAD
8:05 PM
Current molecular techniques and applications in the management of skin disorders
Arivarasan Karunamurthy, MD
8:35 PM
Questions and Answers
Arivarasan Karunamurthy, MD
8:40 PM
Case presentations
Allen Gordon Strickler, MD, PhD, MPH, FAAD
9:10 PM
Questions and Answers
Allen Gordon Strickler, MD, PhD, MPH, FAAD
9:15 PM
Case presentations
Alina G. Bridges, DO, FAAD
9:45 PM
Questions and Answers
Alina G. Bridges, DO, FAAD
9:50 PM
Case presentations
Michi Shinohara, MD, FAAD
10:20 PM
Questions and Answers
Michi Shinohara, MD, FAAD
10:25 PM
Case presentations
Jacqueline M. Junkins-Hopkins, MD, FAAD
10:55 PM
Questions and Answers
Jacqueline M. Junkins-Hopkins, MD, FAAD
SPEAKERS
Alina G. Bridges, DO, FAAD
Zucker School of Medicine at Hofstra/ Northwell
Jacqueline M. Junkins-Hopkins, MD, FAAD
Geisinger Medical Center
Arivarasan Karunamurthy, MD
Department of Dermatology, UPMC
Michi Shinohara, MD, FAAD
Allen Gordon Strickler, MD, PhD, MPH, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Alina G. Bridges, DO, FAAD
No financial relationships exist with ineligible companies.
Jacqueline M. Junkins-Hopkins, MD, FAAD
No financial relationships exist with ineligible companies.
Arivarasan Karunamurthy, MD
No financial relationships exist with ineligible companies.
Michi Shinohara, MD, FAAD
Kyowa Hakko Kirin Pharma, Inc. – Consultant (1099 relationship)(Fees); Kyowa Kirin – Investigator(Grants/Research Funding);
Allen Gordon Strickler, MD, PhD, MPH, FAAD
No financial relationships exist with ineligible companies.